Wird geladen...

Medical Treatment of Benign Prostatic Hyperplasia

Medical therapy for the treatment of benign prostatic hyperplasia (BPH) became an accepted standard of care in the 1990s following the reports of randomized, double-blind, placebo-controlled studies showing that finasteride, a 5-α reductase inhibitor, and terazosin, an α-blocker, significantly impro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Lepor, Herbert
Format: Artigo
Sprache:Inglês
Veröffentlicht: MedReviews, LLC 2011
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3151584/
https://ncbi.nlm.nih.gov/pubmed/21826125
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!